In vivo detection of c-MET expression in a rat hepatocarcinogenesis model using molecularly targeted magnetic resonance imaging

Molecular Imaging

Volumn 6, Issue 1, 2007, Pages 18-29

  Towner, Rheal A ^a   Smith, Nataliya ^a   Tesiram, Yasvir A ^a   Abbott, Andrew ^a   Saunders, Debbie ^a   Blindauer, Rebecca ^a   Herlea, Oana ^a   Silasi Mansat, Robert ^a   Lupu, Florea ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOFLUORESCENCE MICROSCOPIC IMAGING; MALIGNANT PROGRESSION; RAT HEPATOCARCINOGENESIS MODELS;

AMINO ACIDS; ANTIGEN-ANTIBODY REACTIONS; ENZYMES; GROWTH KINETICS; MAGNETIC RESONANCE IMAGING; ONCOLOGY; TISSUE ENGINEERING;

MOLECULAR MODELING;

DIAGNOSTIC AGENT; IRON; MONOCLONAL ANTIBODY; ONCOPROTEIN; OXIDE; PROTEIN TYROSINE KINASE; RON PROTEIN; STREPTAVIDIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL TRANSFORMATION; DISEASE MODEL; EARLY DIAGNOSIS; FISCHER 344 RAT; LIVER TUMOR; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; RAT; TUMOR CELL LINE; VITAMIN DEFICIENCY;

ANIMALS; ANTIBODIES, MONOCLONAL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CHOLINE DEFICIENCY; DISEASE MODELS, ANIMAL; EARLY DIAGNOSIS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; OXIDES; PROTO-ONCOGENE PROTEINS; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; STREPTAVIDIN; TUMOR MARKERS, BIOLOGICAL;

EID: 34247400346     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: 10.2310/7290.2006.00031     Document Type: Article

References (45)

1. Yu Y, Merlino G. Constitutive c-MET signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model. Cancer Res 2002;62:2951-6.
2. Amicone L, Terradillos O, Calvo L, et al. Synergy between truncated c-Met (cyto-Met) and c-Myc in liver oncogenesis: importance of TGF-beta signaling in the control of liver homeostasis and transformation. Oncogene 2002;21:1335-45.
3. Jiang Y, Xu W, Lu J, et al. Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1. Biochem Biophys Res Commun 2001;286:1123-30.
4. DiRenzo MF, Narshimhan RP, Olivero M, et al. Expression of the Met/HGF receptor in normal and neoplastic tissues. Oncogene 1991;6:1997-2003.
5. Yamashita J, Ogawa M, Yamashita S, et al. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res 1994;54:1630-3.
6. Koochekpour S, Jeffers M, Rulong S, et al. Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 1997;57:5391-8.
7. Lamszus K, Liang J, Laterra J, et al. Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 1998;75:19-28.
8. Hendrix EM, Seftor EA, Seftor RE, et al. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/ scatter factor (HGF/SF). Am J Pathol 1998;152:855-63.
9. Moriyama T, Kataoka H, Kawano Y, et al. Comparative analysis of expression of hepatocyte growth factor and its receptor, c-met, in gliomas, meningiomas and schwannomas. Cancer Lett 1998;124:149-55.
10. Ramirez R, Hsu D, Patel A, et al. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMETE) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol (Oxf) 2000;53:635-44.
11. Wallenius V, Hisaoka M, Helou K, et al. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and the presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors. Am J Pathol 2000;156:821-9.
12. Li KCP, Bednarski MD. Vascular-targeted molecular imaging using functionalized polymerized vesicles. J Magn Reson Imaging 2002;16:388-93.
13. 3-targeted magnetic resonance imaging. Nat Med 1998;4:623-6.
14. Konda SD, Aref M, Wang S, et al. Specific targeting of folatedendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts. Magn Reson Mater Phys Biol Med 2001;12:104-13.
15. Artemov D, Mori N, Ravi R, Bhujwalla ZM. Magnetic resonance molecular imaging of the HER-2/neu receptor. Cancer Res 2003;63:2723-7.
16. Vera DR, Buonocore MH, Wisner ER, et al. A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver. Acad Radiol 1995;2:497-506.
17. Reimer P, Weissleder R, Lee AS, et al. Receptor imaging: application to MR imaging of liver cancer. Radiology 1990;177:729-34.
18. De La Vega LA, Stockert RJ. Regulation of the insulin and asialoglycoprotein receptors via cGMP-dependent protein kinase. Am J Physiol Cell Physiol 2000;279:C2037-42.
19. Mendonca-Dias MH, Lauterbur PC. Ferromagnetic particles as contrast agents for magnetic resonance imaging of the liver and spleen. Magn Reson Med 1986;3:328-30.
20. White D. Paramagnetic iron (III) MRI contrast agents. Magn Reson Med 1991;22:309-12.
21. Wiessleder R. Target-specific superparamagnetic MR contrast agents. Magn Reson Med 1991;22:209-12.
22. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanopartides. Magn Reson Med 2003;49:403-8.
23. Stewart BW, Kleihues P. The global burden of cancer. In: Stewart BW, Kleihues P, editors. World cancer report, World Health Organization. Lyon: IARC Press; 2003. p. 12-8.
24. Farber E. Alcohol and other chemicals in the development of hepatocellular carcinoma. Clin Lab Med 1996;16:377.
25. Groopman JD, Cain LG, Kensler TW. Aflatoxin exposure in human populations: measurements and relationship to cancer. CRC Crit Rev Toxicol 1988;19:113-45.
26. Johnson PJ. Hepatocellular carcinoma: is current therapy really altering outcome? Gut 2002;51:459-62.
27. Bannasch P, Zerban H. Experimental chemical hepatocarcinogenesis. In: Okuda K, Tabor E, editors. Liver cancer. New York: Churchill Livingstone; 1997. p. 213-40.
28. Soman NR, Wogan GN. Activation of the c-ki-ras oncogene in aflatoxin B1-induced hepatocellular carcinoma and adenoma in the rat: detection by denaturing gradient gel electrophoresis. Proc Natl Acad Sci U S A 1993;90:2045-9.
29. Towner RA, Mason RP, Reinke LA. In vivo detection of aflatoxininduced lipid free radicals in rat bile. BBA 2002;1573:55-62.
30. Towner RA, Qian SY, Kadiiska MB, Mason RP. In vivo identification of aflatoxin-induced free radicals in rat bile. Free Radic Biol Med 2003;35:1330-40.
31. Murakami H, Sanderson ND, Nagy P, et al. Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 1993;53:1719-23.
32. Nakae D. Endogenous liver carcinogenesis in the rat. Pathol Int 1999;49:1028-42.
33. Nakae D, Kotake Y, Kishida H, et al. Inhibition by phenyl N-tert-butyl nitrone of early phase carcinogenesis in the livers of rats fed a choline-deficient, L-amino acid-defined diet. Cancer Res 1998;58:4548-51.
34. Artemov D, Mori N, Okollie B, Bhujwalla ZM. MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles. Magn Reson Med 2003;49:403-8.
35. Li KCP, Bednarski MD. Vascular-targeted molecular imaging using functionalized polymerized vesicles. J Magn Reson Imaging 2002;16:388-93.
36. Sipkins DA, Gijbels K, Tropper FD, et al. ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. I Neuroimmunol 2000;104:1-9.
37. Zhao M, Beauregard DA, Loizou L, et al. Non-invasive detection of apoptosis using magnetic resonance imaging and targeted contrast agent. Nat Med 2001;7:1241-4.
38. Gentile A, Comoglio PM. Invasive growth: a genetic program. Int J Dev Biol 2004;48:451-6.
39. Stella MC, Trusolino L, Pennacchietti S, Comoglio PM. Negative feedback regulation of the Met-dependent invasive growth by Notch. Mol Cell Biol 2005;25:3982-96.
40. Birchmeyer W, Brinkmann V, Niemann C, et al. Role of HGF/SF and c-Met in morphogenesis and metastasis of epithelial cells. Ciba Found Symp 1997;212:230-40.
41. Wang X, DeFrances MC, Dai Y, et al. A mechanism of cell survival: sequestration of Fas by the HGF receptor Met. Mol Cell 2002;3:411-21.
42. Huh C-G, Factor VM, Sanchez A, et al. Hepatocyte growth factor/c-met signalling pathway is required for efficient liver regeneration and repair. PNAS 2004;101:4477-82.
43. Shaharabany M, Abramovitch R, Kushnir T, et al. In vivo molecular imaging of Met tyrosine kinase growth factor receptor activity in normal organs and breast tumors. Cancer Res 2001;61:4873-8.
44. Tuck AB, Park M, Sterns EE, et al. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am J Pathol 1996;148:225-32.
45. Hay RV, Cao B, Skinner RS, et al. Radioimmunoscintigraphy of tumors autocrine for human Met and hepatocyte growth factor/scatter factor. Mol Imaging 2002;1:56-62.